| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  DiaDeep Every patient matters, every decision counts ! Are you familiar with that moment of hesitation when facing a critical decision, knowing that much is at stake and time is of the essence? This daily challenge is particularly acute for pathologists and oncologists worldwide, especially when making treatment decisions for cancer patients. A minor error in judgment can have far-reaching consequences on numerous lives. To support pathologists and oncologists in these critical decisions, we have developed Ai Copilot applications. These tools assist in decision-making, biomarker quantification, and prognosis prediction, utilizing AI technology and histology slides across various cancers such as breast … Type: | 29 | 5 | 10 | 10 |
 | Matricis.ai Artificial Intelligence for women's health. Matricis.ai brings the best science and cutting-edge machine learning algorithms to endometriosis research. We collaborate with radiologists to co-create medical-grade applications with the goal of improving diagnosis accuracy and democratizing the world's best specialists' expertise for all patients while saving time and reducing medical errancy. Type: | 18 | 7 | 12 | 4 |
 | STH BIOTECH Unlocking the access to innovative ingredients and APIs from cannabis, thanks to plant biotechnology. STH BIOTECH develops unique and reliable plant-biotech process to produce cannabinoids at high yield & low cost. Type: | 14 | 6 | 12 | 12 |
 | CGenetix From hope to reality Young start-up that aims to revolutionize precision medicine by developing innovative and non-invasive diagnostic tests dedicated to monitoring patients with various pathologies. CGenetix is mainly focus on the development of its first diagnostic test dedicated to kidney graft monitoring in transplant patients. biologie moléculaire and Bio-informatique Type: | 9 | 4 | 7 | 4 |
 | Gene&GreenTK Enzymes for agricultural transition Gene&GreenTK (GGTK) is a biotech company created in 2013 and incubated in the IHU of Marseille. The work of GGTK is dedicated to the development and engineering of innovative enzymes isolated from microorganisms living in extreme environments. Enzymes developed by GGTK have two main applications: - Anti-virulence and anti-biofilm for the development of sustainable alternative to conventional antimicrobial agents targeting applications in agriculture, animal nutrition or anti-fouling. - Bioremediation of organophosphorus chemicals for the degradation of insecticides and chemical warfare agents. enzyme, protein engineering, Quorum quenching, organophosphorus decontamination, bioremediation, anti-fouling, biofilm, bacterial virulence, biocatalysis, extremophiles, lactonase, … Type: | 5 | 1 | 0 | 11 |
 | CYNBIOSE Exploring together! We support biopharmaceutical research with translational preclinical models. CYNBIOSE is France-based non-clinical research organization. Preclinical CRO, Pharmacokinetics, POC, Efficacy, Immunotherapies, Drug, Early tox, CNS, Infectious diseases, Respiratory diseases, Non clinical, CRO, PK, PD, and TK Type: | 8 | 3 | 5 | 21 |
 |  Nosopharm Nosopharm is an innovative biotechnology company headquartered in Lyon (France) and specialized in the research and development of new molecules to combat antimicrobial resistance (AMR). The mission of Nosopharm is to discover and develop novel first-in-class anti-infectives addressing unmet medical needs. The innovative anti-infective drug discovery platform developed by Nosopharm is based on the therapeutic exploitation of a very original bioresource: the bacterial genera Xenorhabdus and Photorhabdus. Anti-Infectives, Drug Discovery, Antibiotics, and Microbiology Type: | 13 | 11 | 3 | 4 |
 | Metabrain Research Twist your mind think muscle Metabrain Research is a Biopharmaceutical company developing innovation for Health Industry. We develop preventive and / or therapeutic solutions to cure pathologies linked to metabolic aging (Obesity, Diabetes, NASH, Sarcopenia, Depression and Cognitive Decline). We rely on a collaborative research technology platform combining a large number of expertise (medicinal chemistry, Biology and Pharmacology, Drug Discovery & Development, Nutraceuticals, ...). NASH, Sarcopenia, Obesity, Drug Discovery & Development, Nutraceutical, Biology & Pharmacology, Medicinal chemistry, Cognitive decline, Diabetes, Research&Development, Aging, CRO, Vitro-Vivo models, Active Aging, Metabolic Disorders, Muscle, IA, Cardiorenal disease, and Artificial intelligence Type: | 0 | 0 | 0 | 4 |
 | Dotter.science [Automatic translation follows] Manage your clinical studies with complete peace of mind thanks to our eCRF solution. 👉 https://www.dotter.science/ Dotter.science is an online platform that optimizes the design, entry (eCRF) and electronic management of clinical research protocols. Intended for researchers, healthcare institutions and organizations managing health research protocols, Dotter allows you to save time and gain traceability, while controlling your costs. On Dotter, each researcher has the possibility to manage and carry out their entire protocol on the platform, by minimizing the tedious aspects of clinical studies and securing processes. Clinical research, SaaS, Medical protocols, and Statistical analysis Type: | 3 | 2 | 1 | 2 |
 | Mapatho [Automatic translation follows] The collaborative toolbox for my pathology Mapatho is the collaborative toolbox for my pathology So that each patient has the freedom to choose their caregivers and equal access to experts in their chronic disease by counting on the fraternity of each. With Mapatho, SHARING (one's experience, one's findings) means HELPING (other patients). This is why we are getting more and more involved in helping the 20 million French people with a chronic disease find the resources and information to better live with their disease on a daily basis. On www.mapatho.com, everyone can find all the latest news … Type: | 24 | 2 | 26 | 8 |
 | Planktovie Innovation for Aquatic Animal Research Planktovie’s vision is to develop planktonic nutritional solutions meeting the highest standards for the maintenance of your aquatic animal models, and helping to fulfill the 3Rs (Reduce, Refine, Replace the use of animals for scientific purposes) concept (http://www.nc3rs.org.uk/). Aquatic animal models are gaining in importance as alternatives to more conventional models such as rodents. The use of zebrafish is rapidly expanding in both basic and applied research in areas such as clinical research, pharmacology, and drug discovery. The husbandry requirements of zebrafish, and especially their nutritional needs, have a massive impact on both the number … Type: | 12 | 2 | 10 | 4 |
 | Bio Logbook Precision Healthcare Technology - Innovative data science to detect early biological dysfunctions. Our mission is to enhance patient care through the use of AI and expert systems: Adapting expert systems of industrial excellence, unprecedented in the healthcare field Preventing diseases through early and automatic detection of biological imbalances Maintaining the population's health Bringing new analytical methods to biomedical research. Analyse statistique, Recherche développement en santé, IA en santé, and Système Expert en santé Type: | 12 | 3 | 5 | 10 |
 | BioIntrant [Automatic translation follows] Probiotic Agriculture: Improving Agricultural Productivity Through Plant Health BioIntrant integrates more than thirty years of research at the interface of agronomy, pedology, microbial ecology and bioinformatics, in order to develop biostimulants for modern and responsible agriculture. To do this, BioIntrant integrates the plant into its environment (plant triptych, soil structure, microorganisms) to promote its intrinsic ability to defend itself. It is now possible, thanks to the most advanced technologies and knowledge of the microbial ecology of plants, to restore this natural balance. Biotechnology, Agriculture, Agronomy, Microbiology, Biostimulant, Bioinformatics, and Genomics Type: | 12 | 2 | 11 | 5 |
 | Rising up Paris [Automatic translation follows] Identify, enrich, map and certify your students' soft skills! Rising Up has created THE LAB. the only online soft skills platform capable of assessing, enriching, mapping and certifying soft skills. After more than 7 years of R&D with international experts, Rising Up received in 2023 the Deeptech certification of the European Innovation Council (IEC) judging its technology as a disruptive innovation. More than 3000 students love our solutions. Learning, Digital, formpro, softskills, Neurosciences, Devpro, Training, Telework, and communication Type: | 17 | 3 | 14 | 5 |
 | GL BIOCONTROL GL BIOCONTROL offers innovative products designed to better manage your water systems. For more than 10 years, GL BIOCONTROL is specialized in environmental risk management and is expert in sanitary engineering along with biological monitoring of water and surfaces. Our company offers innovative ATP-metry and qPCR tools for monitoring water, surface and air quality. Our ATP-metry kits, commercialized worldwide, are the most powerful on the market in terms of sensitivity, reliability, easiness to use and rapidity. With a large range of products, our ATP-metry reagents can be used on drinking water as well as on cooling water, process water or … Type: | 13 | 4 | 11 | 14 |
 | Molsid Time is Life. We develop life saving AMR diagnostics that are fast and reliable. Innovative BioMed company, developing a new generation of fluorogenic molecular probes, for applications such as rapid medical diagnostics, drug discovery and medical imaging, but also food quality control. Based on over 15 years of R&D at the prestigious ENS University de Lyon, Molsid’s patented SmartID technology is considered a breakthrough in high quality identification of enzyme activity in live cells. Molsid offers the broadest range of robust fluorogenic precipitation-based probes available on the market. We offer unsurpassed fast and sensitive fluorescence detection for a large panel … Type: | 9 | 3 | 5 | 17 |
 | 4P-Pharma Transforming science into drug success stories Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly. Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty. We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible. Translational research, Biotechnology, Pharmaceuticals, … Type: | 30 | 8 | 25 | 27 |
 |  Apmonia Therapeutics Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Our innovative technological approach is to target tumors overexpressing matricellular protein thrombospondin-1 (TSP-1). Our long-term vision is to develop personalized immunotherapy approaches combining a proprietary therapeutic peptide targeting TSP-1 (namely TAX2 peptide) and a companion diagnostic kit, which may enable patient stratification for TAX2 therapy eligibility based on the monitoring of circulating TSP-1. immunologie and oncologie Type: | 30 | 12 | 20 | 19 |
 | M2I Life Sciences Leader in Integrated pest management; Expert in Biocontrol & Pheromones #nopesticides Molecule Custom Synthesis #CDMO M2I Vision : Build in France a world-class industrial partner for custom synthesis and formulation of niche products in Healthcare (mainly generics), veterinary art, biological crop protection and organic electronics (Re)design synthetic routes and industrial processes for « hard to make » molecules (core capability) Propose to our clients a one stop shop from specification to regulatory clearance (DMF, MA) by teaming up with R&D and marketing teams The company operates a R&D center rance and a cGMP manufacturing plant. M2I holds a portfolio of … Type: | 65 | 16 | 49 | 136 |
 | BioMAdvanced Diagnostics Disrupting the Field of Biomarkers BioMAdvanced Diagnostics is a MedTech start-up based in Nantes, spinoff from the CR2TI (Centre de Recherche Translationnelle en Transplantation et Immunologie, UMR 1064, INSERM – Nantes University) and from the University Hospital (CHU) of Nantes. BioMAdvanced Diagnostics brings a real disruption in the field of Biomarkers based on 20 years of translational research. Its main goal is to enable a really personalized medicine which will greatly improve outcomes for the patient by providing unprecedented tools to clinicians. More specifically, great attention is being placed towards diminishing risks for patients through minimal invasive solutions which will … | 10 | 6 | 7 | 12 |
 | Cilcare MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, … Type: | 43 | 13 | 39 | 44 |
 | 4mg TRANSPARENCY [Automatic translation follows] Manage your core business, we manage its Transparency! Manage your core business, we manage its Transparency! 4mgTRANSPARENCY works with the Health Industry (pharmaceuticals, medical devices, medical visit providers, medical information delegates, Health events, PSAD) and Health Professionals by offering a personalized management solution, internal or outsourced, of regulatory functions and LEA (ex DMOS) from A to Z thanks to comprehensive support on the subject: - Audit of internal LEA (ex DMOS) and Transparency management processes - Management of administrative files (IDAHE, EPS) - Implementation of 4TRANSPARENCY, the innovative, efficient, profitable and agile digital platform that simplifies Transparency … Type: | 40 | 0 | 39 | 3 |
 | Inpart An online platform for scientific partnering helping take discoveries from bench to bedside. Inpart is the leading platform for scientific partnering. We provide comprehensive solutions to facilitate, optimize and track collaborations across industry and academia. In 2022, market-leading biopharma partnering platform Inova successfully merged with IN-PART, a specialized online matchmaking platform focused on fostering collaboration between academia and industry. The strategic union of the two companies as Inpart now offers a powerful platform equipping teams across pharma, biotech, and academia with solutions to showcase innovations and technologies; find untapped science; identify new partners; accelerate deal-making; and manage collaborations. … | 29 | 3 | 23 | 197 |
 | Keen Eye by Tribun Health Computational pathology at scale Keen Eye is the AI platform company that elevates computational pathology to guide better drug development and diagnostics. *** Keen Eye has recently been acquired by Tribun Health*** Tribun Health powers the digital transformation of cancer diagnosis by designing innovative AI-based solutions to enable the management, analysis and sharing of pathology images for diagnostic labs, pharmaceutical and CRO companies. Please also check the Tribun Health website: https://www.tribun.health/ Image analysis, Computational biology, Biotechnology, Deep Learning, Digital Pathology, Artificial Intelligence, Immuno-oncology, Inflammatory diseases, Life Sciences, Image analysis, Biomarker Quantification, Platform, and Drug development Type: | 8 | 5 | 4 | 7 |
 | Coave Therapeutics Coave therapeutics new brand for Horama Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases. Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet … Type: | 7 | 5 | 1 | 36 |
 | ExactCure Our Digital Twin simulates the concentration of drugs in the blood of patients, based on their personal characteristics. ExactCure provides a personalized eHealth software solution. Our VISION is to live in a world where each individual has access to a personalized medication. Our MISSION is to predict the personalized effects and interactions of drugs within the body of each individual. Problem: Inappropriate medical treatments sometimes cause illness. This “iatrogenic” side effect leads to 20,000 deaths and costs €10 billion per year to the public healthcare system in France alone. Worldwide, it probably leads to more than 1 million deaths and … Type: | 43 | 22 | 24 | 23 |
 | AlgoTx AlgoTx develops novel therapeutic solutions for complex pain AlgoTx is a clinical stage biotechnology company developing targeted, first in class therapeutics for peripheral neuropathic pain. Non-opioid, locally acting ATX01 is designed to treat the pain of Chemotherapy-Induced Peripheral Neuropathy, a common and painful side-effect of cancer treatments. It targets the signaling pathways involved in the regulation of pain by selectively inhibiting specific nociceptive sodium channel receptors. FDA granted ATX01 Fast-Track designation. The ACT study is an international Phase II randomized, placebo-controlled trial involving over 270 patients ; The results will be available in early 2025 and the company is making … Type: | 4 | 3 | 2 | 12 |
 | Advicenne Pathbreaking treatment for rare diseases. Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare renal diseases. Advicenne have spent more than 10 years developing products for the treatment of rare renal diseases. At Advicenne, we are committed to developing and commercializing medicines that are suitable for both children and adults – groundbreaking treatments for rare diseases should be available to patients of all ages. Laboratoire Pharmaceutique | 0 | 0 | 0 | 23 |
 | POXEL Poxel is a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare disorders. Poxel has clinical and earlier-stage programs from its adenosine monophosphate-activated protein kinase (AMPK) activator and deuterated TZD platforms targeting chronic and rare metabolic diseases. For the treatment of NASH, PXL065 (deuterium-stabilized R-pioglitazone) is in a streamlined Phase 2 trial (DESTINY1). PXL770, a first-in-class direct AMPK activator, has successfully completed a Phase 2a proof-of-concept trial for the treatment of NASH, which met its objectives. For the rare inherited metabolic disorder, adrenoleukodystrophy (ALD), the company intends to initiate … Type: | 2 | 2 | 0 | 26 |
 | KADALYS La première marque éco consciente et bio experte de la science du bananier KADALYS is the first organic and eco-conscious skincare brand that upcycles banana agri-waste into patented and clinically proven bio-actives that rejuvenate skin. Inspired by French Caribbean traditional medicine, and backed by 10 years of research, KADALYS products are certified organic, vegan, and cruelty-free while adhering to ethical, sustainable, and fair-trade practices. All planters are also shareholders. The brand's ingredients are sourced and manufactured in an ethical and eco-friendly way. KADALYS is Black and female founded. --------- Première marque de cosmétologie naturelle aux actifs de Bananier Soins anti-âge … Type: | 16 | 9 | 5 | 15 |
 | MEERSENS Environmental intelligence for smart decisions. Mitigate environmental risks & positively contribute to health/wellbeing Meersens - certified #GreenTech & #DeepTech - is a positively impactful company in the field of environmental health (☁️ air, 💧water, 📣 noise, 🌻 pollen, 🔥 fire, 🌦️ weather, ☀️UV...). Our mission: to build a sustainable future by mitigating environmental risks and promoting the well-being of all stakeholders - by offering personalized environmental monitoring and prevention. Thanks to our cutting-edge tools (SaaS, API, IoT, App), you benefit from 360°, real-time, historical, and predictive information on a multitude of pollutants, for any location. This high precision data enables … Type: | 76 | 16 | 72 | 12 |
 | Bioxegy Pioneering biomimicry in Europe. Together with your R&D-I teams, we engineer breakthrough bio-inspired technologies. A new ally for your innovation : 3.8 billion years of R&D. At Bioxegy, we stand for a world where mankind thrives and progresses in harmony with its environment. In today’s context of constant challenges and strong competitive pressure, this is a major challenge for companies. We believe that their success will first and foremost rely on their capacity to imagine and explore new ways to innovate. Combining competitivity and sustainable development is now paramount. To answer this challenge, Bioxegy relies on more than 3.8 billion … Type: | 29 | 4 | 24 | 27 |
 | HypnoVR Treating pain and anxiety differently. HypnoVR is a medical device combining the benefits of medical hypnosis with virtual reality. Designed by two anesthesiologists and hypnotists with more than 15 years of experience, HypnoVR has demonstrated its effectiveness in the treatment of pain and anxiety through 15 clinical studies (postoperative length of stay divided by 3.57 and 45% reduction in morphine consumption). HypnoVR is a simple and quick tool for health professionals, especially those specialized in anesthesia, surgery and dental surgery. It complies with the hygiene standards of health institutions and medical practices: HypnoVR adapts to your care organization with a … Type: | 36 | 18 | 22 | 35 |
 | Continuum Plus Santé [Automatic translation follows] Reinventing the monitoring of patients under anticancer drugs #AKOadom, Continuum+ Connect Telemonitoring Platform Closer to patients. cancer, health, digital, E-health, Home support, and telemonitoring Type: | 39 | 8 | 34 | 19 |
 | Aenitis Technologies Acoustic Cell Processing Solution 🚀 Aenitis designs, develops, and markets sole-in-class acoustofluidic technology that makes cell and gene therapy manufacturing better, safer, and less expensive. By precisely controlling levitated cells with sound waves, our systems handle cells in full sterile conditions and radically increase productivity while preserving the native state of cells at every step of the engineering process. This technology enables gentle, non-invasive manipulation of cells at the millifluidic scale, allowing for the handling of tens of milliliters per minute. Such capabilities are critical for scaling applications from research to clinical and industrial use. 💡Today, we have achieved proof-of-concepts … Type: | 21 | 5 | 17 | 17 |
 | InBrain Pharma InBrain Pharma, a CNS disorders focused biotech, founded in 2018, exploiting through an exclusive worldwide patent license signed with the Northern France TTO, a groundbreaking therapeutic approach of advanced Parkinson’s Disease based on the research work of Pr David DEVOS and Pr Caroline MOREAU developed within their academic research Team from the Université́ de Lille, Lille Neuroscience & cognition UMR-S 1172 INSERM and the Lille University Hospital. To date, the company has raised €4.4 million in dilutive and non-dilutive financing, these funds having enabled to carry out a first phase I/IIb DIVE-I clinical trial on 12 patients, for which results … Type: | 13 | 5 | 9 | 4 |
 | BioC3 Synthetic Biology BioC3 is a French biotech startup that has created an innovative biocatalysis platform. This brings standardized and highly efficient reaction cascades thanks to stabilized enzymes. The reactions take place in water at ambient temperature and atmospheric pressure, using carbon sources that are renewable. No polluting by-product is generated. Type: | 0 | 0 | 0 | 10 |
 | Pixience La nouvelle ère de la dermoscopie Pixience is specialized in measurement and imaging devices for skin exploration. Manufacturer of the "C-Cube Dermatology": digital dermatoscope dedicated to the dermatology practice for early detection of skin cancer. Based on its scientific expertise in skin measurement, Pixience produces the "C-Cube Clinical Research" first 2D & 3D imaging colorimeter used by laboratories for cosmetics claims assesment and research on the skin. Healthcare technology solutions, Engineering, Image Analysis, Skin Evaluation, Support for Clinical Trials, and Biometrology Type: | 6 | 2 | 3 | 11 |
 | DIAG2TEC Preclinical CRO in Hematological Cancers Diag2Tec is an expert preclinical CRO devoted to hematological cancers, especially Multiple Myeloma (MM). We focused on in vitro Drug Testing in Human Hematological Cancer derived Cell Lines and Primary Cells from patients with various Hematologic Malignancies (Multiple Myeloma, Diffuse Large B Cells Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), Mantle cell Lymphoma, Chronic Lymphoid Leukemia...). With our 2 platforms : Drug Testing Services and ChimioFx, our mission is to provide efficient treatment solutions for patients suffering from Hematological Malignancies with Precision Medicine approaches. We support biotech and phamaceutical companies to focus their drug development on … Type: | 2 | 2 | 0 | 8 |
 | NeoVirTech Virus and viral vector imaging in living cells applied to antiviral discovery and disinfection processes NeoVirTech (NVT) is one of the leading virus imaging and antiviral discovery company in Europe. The company has been highlighted in the Top10 drug discovery companies, Europe, 2019 by the PharmaTechOutlook Magazine. NVT has developed a breakthrough technology to directly visualize and quantify in real time virus/viral vector infection and replication in living cells, from high resolution to high content imaging. At NeoVirTech, we believe everyone can have access to state-of-the-art virology techniques. We are focusing our activities on antiviral discovery, study of oncolytic and … Type: | 13 | 2 | 6 | 6 |
 | ODONTELLA [Automatic translation follows] The company has filed patents relating to the use of Odontella, the world's first marine microalgae authorized for human consumption. These patents concern the formulation, based on the marine microalgae Odontella, of a wide range of new agri-food products, healthy for the whole family. (Beverages, ready meals, etc.) The company is working on a new value chain, based on Odontella, by developing the first marine plant-based salmon that can directly replace the consumption of farmed salmon, in terms of taste, appearance, texture, nutritional quality and also price. This patented product developed in partnership with specialized laboratories is … Type: | 3 | 2 | 0 | 2 |
 | Kaer Labs In vivo small and large animal near infrared fluorescence imaging Kaer Labs develops and sells innovative in vivo fluorescence imaging solutions for researchers. Our systems are used by academic and private laboratories working on medical or pharmaceutical research In vivo near infrared fluorescence, Molecular Imaging, and Small and large animal open fluorescence Type: | 4 | 3 | 0 | 6 |
 | Qynapse The future of neuroimaging is here. Qynapse offers groundbreaking peace of mind by providing results you can trust. The future of neuroimaging analysis is here and Qynapse is leading the way. For clinicians on the front lines, for patients and their families, for payers, and for pharma – we offer peace of mind by providing results you can trust. Headquartered in France, in the United States and in Canada, the Qynapse team, with our world-renowned team of scientific and clinical partners, is wholly dedicated to aspiring to bring the entire neuroscience community and their patients the clearest, most accurate and … Type: | 13 | 5 | 8 | 24 |
 | Australian Institute for Bioengineering and Nanotechnology AIBN Urgent solutions are needed for global problems. At the AIBN we are working on the answers. The University of Queensland's Australian Institute for Bioengineering and Nanotechnology (AIBN) is an integrated multi-disciplinary research institute bringing together the skills of world-class researchers in the areas of bioengineering and nanotechnology. It is home to 18 research groups working at the interface of the biological, chemical and physical science to alleviate current problems in human health and environmental issues. The Institute has three key areas that collectively distinguish it from other institutes in the country, namely AIBN's: - Research excellence; - Industry focus; and … Type: | 12 | 0 | 11 | 150 |
 | UQ Institute for Molecular Bioscience Bringing together scientists to solve the world's complex problems. IMB is a multidisciplinary life sciences research institute at The University of Queensland. Our 500 scientists from across the globe use world-leading infrastructure to drive discoveries from genome to drug design, disease discovery application and sustainable futures. Our research is framed through centres focused on: * superbugs * pain * heart disease * inflammation * solar biotechnology * genomics-disease interplay IMB’s combination of life, pharmacological and chemical researchers means that the Institute can take life science discoveries from genome to drug design and application – for health, disease and for the … Type: | 33 | 9 | 13 | 164 |
 | MassBio Massachusetts is the State of Possible - the #1 life sciences cluster in the world - and we plan to keep it that way! MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts life sciences industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system and improve patient lives. Representing more than 1000 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and healthcare, MassBio works to advance policy … Type: | 43 | 13 | 34 | 103 |
 | CiMUS (Center for Research in Molecular Medicine and Chronic Diseases) The Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) promotes the development of interdisciplinary research in the field of biomedical sciences, through the interaction and collaboration of integrated teams in the center, and with relevant national and international groups. CiMUS has been awarded CIGUS recognition by the Xunta de Galicia, which accredits the quality and impact of its research (ED431G/2023/02)-------El CiMUS cuenta con el reconocimiento CIGUS de la Xunta de Galicia, que acredita la calidad e impacto de su investigación (ED431G/2023/02). . Cancer, Endocrinology and Nutrition, and Neuroscience Type: | 9 | 1 | 7 | 143 |
 | Vanderbilt Vaccine Center Committed to impacting global health through the development of new therapeutics and vaccines for infectious diseases. We are committed to impacting global health through fundamental research that fosters development and testing of new vaccines for infectious diseases. Our international team of scientists and physicians focuses on work with major human pathogens, especially microbial threats that affect the most vulnerable subjects such as infants and the elderly. Many of the targets we study are particularly important in developing world settings. We also conduct research related to biodefense and emerging infectious diseases. Type: | 6 | 0 | 3 | 3 |
 | Sainsbury Laboratory Cambridge University (SLCU) Sainsbury Laboratory Cambridge University (SLCU) is a research institute dedicated to understanding plant growth. The Sainsbury Laboratory Cambridge University (SLCU) is a research institute funded by the Gatsby Charitable Foundation. The aim of the Laboratory is to elucidate the regulatory systems underlying plant growth and development. Plants are the foundation for virtually every ecosystem and agricultural system on Earth. A fundamental understanding of how plants grow and develop is therefore paramount for the long term security of a sustainable supply of food and other plant products, such as fuel, fibres and building materials. The study of plant development is being … Type: | 3 | 2 | 1 | 79 |
 | The Pirbright Institute Preventing and controlling viral diseases of livestock and those that spread from animals to people. The Pirbright Institute is a world leading centre of excellence in research and surveillance of virus diseases of farm animals and viruses that spread from animals to humans. Working to enhance capability to contain, control and eliminate these economically and medically important diseases, the Institute's highly innovative fundamental and applied bioscience contributes to global food security and health, improving quality of life for animals and people. science, research, zoonoses, vaccines, viral diseases, disease control, diagnostics, animal health, and food security Type: | 7 | 3 | 2 | 410 |
 | Keystone Symposia on Molecular & Cellular Biology Accelerating Life Science Discovery Keystone Symposia on Molecular and Cellular Biology is committed to connecting the scientific community across disciplines and borders by convening open, international conferences on the cutting edge of the biomedical and life sciences. Our goal is to be a catalyst for generating new ideas and accelerating life science discovery. Our 2017-2018 conference series consists of 60 conferences worldwide across a wide range of the life sciences. In 2017, we mark the 45th anniversary of our founding in 1972 as the UCLA Symposia on Molecular and Cellular Biology. In 1990 we became a subsidiary of The Keystone … Type: | 9 | 1 | 6 | 56 |
 | John Innes Centre An independent, international centre of excellence in plant science, genetics and microbiology The John Innes Centre is an independent, international centre of excellence in plant science and microbiology. Our mission is to generate knowledge of plants and microbes through innovative research, to train scientists for the future, to apply our knowledge to benefit agriculture, the environment, human health and well-being, and engage with policy makers and the public. The research we do makes use of a wide range of disciplines in biological and chemical sciences, including microbiology, cell biology, biochemistry, chemistry, genetics, molecular biology, computational and mathematical biology. plant biology, … Type: | 15 | 3 | 8 | 467 |
 | American Society of Gene & Cell Therapy ASGCT is the primary membership organization for professionals working in gene and cell therapy. The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, and biotechnology and pharmaceutical companies. The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT's strategic vision is to be a catalyst for … Type: | 15 | 1 | 15 | 66 |
 | Guardant Health Conquering Cancer With Data Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, we're transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant Health has commercially launched Guardant360®, Guardant360® CDx, Guardant360 TissueNext®, Guardant360 ResponseTM, and GuardantINFINITYTM tests for advanced-stage cancer patients, and Guardant Reveal® for early-stage cancer patients. The Guardant Health screening portfolio, including the FDA-approved ShieldTM test, aims to address the needs of individuals eligible for cancer screening. Type: | 17 | 5 | 11 | 3,062 |
 | King Pharmaceuticals King, an S&P 500 Index company, is a vertically integrated branded pharmaceutical company that develops, manufactures and markets therapies and technologies primarily in specialty-driven markets including neuroscience, hospital and acute care medicines. King’s business model offers the best qualities of a big and small company in one fully integrated pharmaceutical company. Our size enables us to build close personal relationships with the medical community and flexible collaborative partnerships with other pharmaceutical companies. Fully integrated resources in scientific and technical operations, coupled with a fully aligned sales force, enable us to move quickly to capitalize on scientific advances and bring innovative … Type: | 0 | 0 | 0 | 326 |
 | Euro-BioImaging European Research Infrastructure for Imaging in Biological & Biomedical Sciences Euro-BioImaging is the European landmark research infrastructure for biological and biomedical imaging as recognised by the European Strategy Forum on Research Infrastructures (ESFRI), and with the ERIC legal status (European Research Infrastructure Consortium) by the European Commission in November 2019. Euro-BioImaging ERIC is a joint effort of 18 countries and EMBL. The mission of Euro-BioImaging ERIC as a distributed research infrastructure is to provide open access to world-class imaging services, training opportunities, data management services and expertise at nearly 200 world-class imaging facilities across Europe organised in Nodes. Every researcher … Type: | 8 | 2 | 6 | 33 |
 | Rochester Regional Health Rochester Regional Health, headquartered in Rochester, NY, is an integrated health services organization serving the people of Western New York, the Finger Lakes, St. Lawrence County, and beyond. We are dedicated to helping our community stay healthy and live fulfilling lives. Together, we find the best way forward to where you want to be. From western to northern New York, rest assured; we’ve got you covered. We see you. We’re with you. We’re here to uplift you—to treat people, not symptoms. To treat you well. Our experience is nation-leading, neighbor-driven, and rooted in generations of real-life care. Today, we offer … Type: | 1 | 0 | 0 | 10,117 |
 | Business Kemi - Digipolis #Digipolis #BusinessKemi #Kiertotalouskeskus #InvestinKemi #InvestinVeitsiluoto #paremmanbisneksenpuolesta Digipolis - Kemi technology park is Lapland's largest technology centre and it has been in operation since 1993. Digipolis is home to over 50 companies and organisations and approximately 500 employees. Digipolis is also a centre for education; the Lapland University of Applied Sciences and Lappia Vocational College provide education for 1,500 students. Digipolis meets companies' development challenges particularly at the interface of information and processing industries but also in other interfaces of information industry, such as cold and extreme conditions. Digipolis' strongest areas of special expertise have been honed with determination over the … | 2 | 1 | 1 | 4 |
 | BIOPHYTIS - Live Healthier Longer Société de biotechnologie au stade clinique axée sur le développement de son principal candidat médicament, RUVEMBRI Biophytis SA is a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging. Our small molecules are aimed at stimulating biological resilience to stress during aging. Ruvembri - in regulatory and clinical phases - is our leading drug candidate is administered orally: • for the treatment of severe respiratory events related to COVID-19 following positive results in Phase 2/3 clinical study (COVA) • for the treatment of reduced mobility in elderly patients with … Type: | 3 | 1 | 1 | 23 |
 | ADOCIA "Innovative medicine for everyone, everywhere" "Innovative medicine for everyone, everywhere" Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia is specialized in diabetes and obesity. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients. For more information, visit our website: www.adocia.com For careers offers, please click to the following link : https://www.adocia.com/careers/adocia-careers/ Therapeutic proteins, BioChaperone®, Next-generation injectables for diabetes treatment, Ultra-rapid Insulin, Multi-agents injectable combination, Diabetes, Metabolic … Type: | 4 | 2 | 2 | 88 |
 | Quantum Genomics The objective of Quantum Genomics is to become a leading actor in the treatment of cardio-vascular diseases through the development of a new therapeutic class: BAPAIs for BrainAminopeptidase A Inhibitors. We wish to develop and provide effective and well tolerated therapeutic treatments for controlling high blood pressure and to for preventing related cardio-vascular risks such as heart failure. High blood pressure remains a major public health concern. Quantum Genomics is the only biopharmaceutical research company developing new therapies from a real breakthrough innovation based on the inhibition of brain Aminopeptidase A. The mid-term strategic objective of the company is to … Type: | 6 | 4 | 2 | 4 |
 | Neuroservice In vitro Slice Electrophysiology for CNS and Pain Research NEUROSERVICE is a private Contract Research Organization (CRO) providing pharmacological assays based on electrophysiological recordings of acute brain slices, spinal cord slices, neuronal cultures, human brain slices and iPSC-derived neurons. These assays are performed with two complementary techniques: Multi-Electrode Array (MEA) and Patch-Clamp. The mission of NEUROSERVICE is to support the early phases of CNS and PAIN R&D programs in Lead Selection & Optimization as well as in the investigation of Mechanism of Action for pre-clinical compounds. NEUROSERVICE is also able to perform electrophysiological recordings of slices from genetically engineered rodents … Type: | 7 | 3 | 2 | 6 |
 | Odysséa Organisation [Automatic translation follows] Together we are even stronger Between running, walking, smiles and conviviality, Odysséa supports the fight against breast cancer 🎀 All year long our 3,500 volunteers, partners and local supporters mobilize throughout France and Overseas to offer you beautiful pink waves! Accessible to all 🏃🏃♀️👨👩👧👦, we invite you to one of our stopover cities to experience a strong moment of solidarity as a team, colleagues, family or friends 🤝 To find out everything about our events ➡️ https://odyssea.info You have questions about group and business participation ➡️ contact@odyssea.info Find us on: Instagram: @odyssea_fr Facebook: https://www.facebook.com/ODYSSEA.fr/ #ensembleonestencoreplusfort Sports Events, … Type: | 100 | 81 | 13 | 12 |
 | C.RIS Pharma Your partner for your preclinical development ! C.RIS Pharma is a french Contract Organization (CRO), GLP certified, specialized in in vitro and in vivo preclinical development of new active molecules against human diseases, but also in Agrofood and Cosmetic area. | 0 | 0 | 0 | 21 |
 | Innobiochips Innobiochips develops the SirYus technology, a disruptive way to design, manufacture and read multiplex immunoassays, paving the way for innovative diagnostics solutions for human health. Fast, reliable, powerful: SirYus technology takes in vitro diagnostics to the next level and opens new possibilities : #transplantation - #transfusion - #InfectiousDiseases - #microbiome | 7 | 2 | 4 | 19 |
 | IBMC [Automatic translation follows] The Institute of Molecular and Cellular Biology is made up of UPR 9002, UPR 9021 and UPR 9022, CNRS Research Units. Such a grouping of research units, although developing distinct themes, encourages interactions between scientists of different origins and training in order to allow the emergence of new research programs using cross-skills. In addition, bringing together the three Units under one roof leads to the pooling of certain materials and techniques and to the rational development of methodological platforms. The thematic field structuring the teams of UPR 9002 (Architecture and Reactivity of RNA, RNA) is centered on … Type: | 1 | 1 | 0 | 142 |
 | Green City Solutions GmbH We grow fresh air! #CityTree #CityBreeze #WallBreeze 🍃 We grow fresh air - with moss, naturally. More than half of humanity lives in cities – and the trend is rising. Cities are clearly the living space of the future. And yet our most important resource, the air we breathe, is in many places so polluted that breathing is harming our health. In the future we have in mind, fresh air in urban areas is available to everyone. That’s why we developed the world’s first regenerative bio-tech filters for verifiable improvements in air quality. #WeGrowFreshAir with CityTree, CityBreeze and WallBreeze. Moos, … Type: | 44 | 4 | 38 | 34 |
 | Nanoscribe Make small things matter. In 2007, a team of researchers from Karlsruhe Institute of Technology (KIT) set out to rethink microfabrication. At that time, Two-Photon Polymerization (2PP), the underlying core physics and chemistry for the Nanoscribe technology, was a small niche research topic. The founders however recognized the potential and made 2PP-based 3D printers commercially available. Besides the 2PP-based 3D Microfabrication technology, Nanoscribe revealed its proprietary Two-Photon Grayscale Lithography (2GL ®) with presenting the maskless lithography platform Quantum X in 2019. 2GL combines 2PP with the qualities of grayscale lithography and thus enables rapid and precise microfabrication of ultra-smooth surfaces … Type: | 5 | 0 | 3 | 74 |
 | OakLabs Scientific Reach New Heights With Your Biomarkers At OakLabs Scientific, we believe that each of us can live longer healthy. In a society where individual healthcare is increasingly challenging, we are pioneering ways to detect and avert disease before it occurs. Using our unique Artificial Intelligence algorithms and high-molecular-weight data, we are exploring individual health status in unprecedented depth. gene expression analysis, biotechnology, research, biomarkers, biomarker signatures, and companion diagnostics Type: | 1 | 1 | 0 | 6 |
 | ChromoTek new tools for better research #newtoolsforbetterresearch Part of Proteintech Group. ChromoTek pioneered the development and commercialization of alpaca Nanobodies. As a market and product leader for high quality and reliable Nanobody-based reagents, we assist scientists’ research world-wide. In addition, ChromoTek is a trusted service provider of custom-made Nanobodies for the pharmaceutical industry. Founded in 2008 ChromoTek has offices in Martinsried, Germany, and Hauppauge, NY. In contrast to traditional antibodies Nanobodies consist of only one single polypeptide chain; they are 15 kDa and the smallest antibodies known. ChromoTek GmbH, Affinity purification, Immunoprecipitation, Co-IP, Mass spectrometry, Ligand capture, Protein-protein interaction, GFP-Trap, Fluorescent … Type: | 2 | 1 | 1 | 17 |
 | Life Supporting Technologies Innovation comming to life Life Supporting Technologies (LifeSTech) is a research, development and innovation group, located within the Universidad Politecnica de Madrid (UPM) and dedicated to design, development and evaluation of services and applications based on ICT, to create and promote new ideas, methods and technological solutions to improve people's lives. e-Learning, e-Inclusion, and e-Government | 4 | 1 | 3 | 25 |
 | Veracyte, Inc. High-value insights, high-impact decisions Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our growing menu of diagnostic tests answers important clinical questions to help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment. | 6 | 3 | 1 | 591 |
 | Kiyatec Inc. Changing the future of cancer care by accurately predicting patient response to therapies before treatment begins Kiyatec is disrupting cancer care by accurately predicting patient–specific response and non–response before treatment begins. We utilize the patient’s own living tumor cells to create functional 3D models to test a battery of cancer therapies in our CLIA-certified and research laboratories. Our goal is to enable physicians to isolate only the effective treatments for their patients as quickly as possible - making true personalized medicine a reality. Our approach has been validated through engagements with leading cancer hospitals, multiple top 10 pharmaceutical companies and … Type: | 1 | 0 | 1 | 21 |
 | Seres Therapeutics Leading the Microbiome revolution Seres Therapeutics is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Our lead program, VOWSTTM, obtained U.S. FDA approval in April 2023 as the first orally administered microbiota-based therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. We are evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation to reduce incidences of gastrointestinal infections, bloodstream infections, and graft-versus-host disease as well as additional preclinical stage programs targeting Infection Protection in … Type: | 3 | 1 | 1 | 240 |
 | BioVersys AG Leadership in overcoming the antibiotic resistance crisis. BioVersys AG is a privately-owned clinical stage Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in antimicrobial resistance (AMR) and targeted microbiome modulation. With the company’s award-winning TRIC technology we can overcome resistance mechanisms, block virulence production and directly affect the pathogenesis of harmful bacteria, towards the identification of new treatment options in the antimicrobial and microbiome fields. By this means, BioVersys addresses the high unmet medical need for new treatments against life-threatening resistant bacterial infections and bacteria-exacerbated chronic inflammatory microbiome disorders. Our … | 1 | 0 | 1 | 26 |
 | MRM Health Redefining microbiome-based therapeutics MRM Health NV is a biopharmaceutical company focused on the discovery and development of innovative therapeutics based on the human microbiome.The company is based in a Center of Expertise for microbiome research and development in the biotech cluster in Ghent, Belgium, and has a strategic partnership with the VIB, with top research groups in both microbiome analysis and ecology and in host biology and disease research. The Company is strategically supported by strong local and international investors, including Ackermans & van Haaren, DuPont, MRM Technologies, Qbic II and VIB and has a corporate collaboration with DuPont Nutrition … Type: | 1 | 1 | 0 | 43 |
 | MV BioTherapeutics SA A Microbiota biotherapeutics and Vaccines company. Conditioning the gut ecosystem for disease prevention and therapy. Spin-off from the Institute for Research in Biomedicine (IRB) in Bellinzona, Switzerland, aimed at shaping the intestinal microbiota for the cure and prevention of diseases such as bowel diseases and cancer. The gut ecosystem conditions the function of all our organs and plays a fundamental role in our wellbeing. The mucosal immune system has co-evolved with the intestinal microbiota to adapt its function to a number of environmental and possibly pathogenic factors. MV Bio leverages a microbiota-mediated mechanism regulating the physiological response of the intestinal … Type: | 1 | 1 | 0 | 1 |
 | OPPILOTECH LTD Navigating Biology, Discovering Drugs Oppilotech have developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. We use the models to simulate biological processes in order to identify viable drug targets and discover new biology. The company is building a pipeline of first-in-class drug discovery programmes based on the identified targets. Type: | 1 | 1 | 0 | 11 |
 | PEPperPRINT GmbH The leading provider of high-density peptide microarrays for antibody validation, epitope mapping & antigen discovery. PEPperPRINT is an innovative biotech company from Heidelberg, Germany, and the leading provider of high density peptide and protein microarrays for antibody characterization or the fingerprint analysis of antibody responses from biological samples. The product and service portfolio was recently complemented by T cell epitope mapping and monitoring, making PEPperPRINT a one-stop solution provider for the fingerprint analysis of immune responses e.g. for epitope mapping, antibody biomarker discovery or the analysis of adverse immune effects. PEPperPRINT’s peptide microarrays and screening services have been used by … Type: | 1 | 1 | 0 | 24 |
 | GQ Bio Therapeutics High-Capacity Gene Therapy Vector Platform to Address Prevalent Diseases GQ Bio is pioneering a high-capacity gene therapy vector platform (HCAd) that addresses some of the big challenges in the gene therapy field: Transfer of large and multiple genes with a single vector, highly efficient gene delivery (high transduction efficiency), and large-scale manufacturability. Based on its HCAd vector platform, GQ Bio develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration. GQ Bio is headquartered in Hamburg, Germany and has sites at Luckenwalde (greater Berlin area), Germany and Liège, Belgium. biotechnology, gene therapy, osteoarthritis, drug development, human … Type: | 3 | 2 | 0 | 18 |
 | Kropz Elandsfontein Responsible rock phosphate exploration, mining and processing. Focused on responsible rock phosphate exploration, mining and processing. Our mission is to set a new standard in the green mining of fertiliser feed minerals and to develop a world class plant nutrient fertiliser production and distribution capacity that will meaningfully contribute towards feeding sub-Saharan Africa for generations to come. Due to the low cadmium and other heavy metal content of Kropz Elandsfontein’s rock phosphate is also a member of Safer Phosphates. Phosphate Mining and SA's second largest Phosphate deposit | 0 | 0 | 0 | 11 |
 | Memo Therapeutics AG Memo Therapeutics AG (“MTx”) is a late-stage biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer. The Company’s lead program, Potravitug, is in Phase II development targeting BK viremia (BKV) in kidney transplant recipients, an infection which can result in decreased kidney functionality and longevity and reduced patient survival. Potravitug has the potential to become the best and first-in-class BKV disease-modifying therapy for kidney transplant patients. Alongside Potravitug, MTx is focused on discovering novel antibody-target pairs for oncology based on tumor infiltrating B-cells derived leveraging tertiary lymphoid … Type: | 3 | 2 | 2 | 43 |
 | VarmX VarmX is a young biotech company focusing on the development of therapies in the field of hemostasis and thrombosis. VarmX (www.varmx.com) is a young Leiden based biotech company that is focusing on the development of therapies in the field of hemostasis and thrombosis. Originally a spin-off from the Leiden University Medical Center (LUMC), our mission is to develop and manufacture therapeutic proteins to restore hemostasis. Our lead compound, VMX-C001, is intended to safely and effectively restore hemostasis in case of bleeding or emergency surgery in patients taking so-called oral factor Xa inhibitors. The VarmX program has gained significant interest in … Type: | 0 | 0 | 0 | 26 |
 | Minervax ApS Developing a maternal vaccine for Group B Streptococcus MinervaX is pursuing the development of a maternal vaccine for the prevention of adverse pregnancy outcomes and life-threating infections caused by Group B streptococcus (GBS). The vaccine is based on adjuvanted proteins antigens covering close to 100% of clinical GBS isolates. Group B Streptococcal (GBS) is the leading cause of life-threatening infections in newborns. Colonization of pregnant women with GBS may lead to adverse pregnancy outcomes such as late abortions, stillbirths, and preterm delivery. Colonization may also lead to life-threatening infections in newborns for the first 3 months of life, causing pneumonia, … Type: | 0 | 0 | 0 | 62 |
 | MoonLake Immunotherapeutics (NASDAQ: MLTX) Creating next-level therapies for inflammatory skin and joint diseases with Nanobody® science MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. Immunotherapy, inflammatory skin & joint diseases, partnering, IL17A / F, #MLTX, #Nanobody, #HS, #PsA, and #IL17 | 3 | 1 | 2 | 95 |
 | Acousia Therapeutics GmbH Enhance & Preserve Natural Hearing ! Acousia is a pioneer of novel medicines. Founded in 2012, the company’s experienced and entrepreneurial management team is committed to combating hearing loss. Thanks to its exclusive collaboration agreement with the renowned Translational Hearing Research Group of Tuebingen University Clinic and an ecosystem of experts and CROs, Acousia has made significant strides with its advanced small molecule drug candidates. Hearing Loss Treatment and Hearing Loss Drug Development Type: | 1 | 0 | 0 | 5 |
 | MolDrug Chemoinformatics and modeling solutions to optimize your drug candidates. MolDrug (a ProtoQSAR company) is a group specializing in the design and optimization of molecules through Machine Learning-powered chemoinformatics and structural bioinformatics. Our models allow for the prediction of molecular properties (QSAR) and detailed interaction analyses (molecular modelling). We work with all types of compounds, including small molecules, peptides, nanomaterials, mixtures... Our tools allow for the prediction and assessment of physicochemical, biological, pharmacological, and/or (eco)toxicological properties of substances with an array of advantages: - faster results - saving money and resources - reduce animal testing (3 Rs) - regulatory validity (REACH, … Type: | 0 | 0 | 0 | 3 |
 | Relation Discovering the relationships at the heart of biology to cure disease. We are an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of life's most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure. Medicines born from high-resolution biology, machine learning and clinical insights. Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select … Type: | 11 | 0 | 9 | 75 |
 | LDMH Partners Life Sciences Advisors. UK | EU | North America We are a niche life sciences advisory firm, and a full service law firm, with exceptional expertise in human tissue- and cell-based research, clinical care, and assisted reproduction. We advise established biotechnology companies as well as start-ups, fertility clinics, and biobanks. medical ethics, data protection, medical law, autonomy, biotechnology, clinical trials, consent, GDPR, Law, and Life sciences law Type: | 0 | 0 | 0 | 7 |
 | Crafting Future Wir produzieren nachhaltige Mehrwegbehälter und entwickeln gemeinsam die für dich passende Mehrweglösung Disposable waste is one of the biggest problems of our time. At the same time we know that there will never be a world without plastics. That is why we have made it our mission to question the plastics industry. In our material selection, product design and product development, we place a special focus on the end of a product's life cycle. In doing so, we consider the recovery of an equivalent amount of plastic compared to the amount used in manufacturing. We develop our own reusable products … Type: | 4 | 0 | 4 | 10 |
 | siTOOLs Biotech GmbH High Specificity Tools for RNAi, rRNA depletion & RNA Interactome Studies. Services: Making Sense of RNAi Screening Data We drive RNA research with tailored molecular tools. We are from Munich and provide researchers with highly complex & advanced genetic tools. Our core expertise is RNA interference, bioinformatics, and RNA research tools for RNA-Seq and Ribo-Seq. Distinguished by their exceptional targeting specificity and efficiency, our gene function analysis tools include - siPOOLTM for reliable gene silencing, raPOOLTM for targeted RNA affinity purification and riboPOOLTM for efficient ribosomal RNA depletion. Our technology combines high complexity oligo pooling (“Pack Hunter” approach), proprietary design … Type: | 1 | 0 | 1 | 10 |
 | Oculyze One of the leading platforms for cloud based quantitative image recognition. Using machine learning and Artificial Intelligence Oculyze has transferred the computer vision software for lab equipment from the table top to the cloud. To prove this revolutionary approach works and is market ready, Oculyze launched the yeast cell counters for breweries and wineries. This device works using a microscope connected to a smartphone and the Oculyze app to upload the images to the cloud where they are analysed by image recognition algorithms. These combine methodical pattern recognition with artificial intelligence and deep learning to offer quantitative real-time image analysis. … Type: | 3 | 2 | 1 | 7 |
 | CYTENA We make the development of modern therapies faster, safer, and more affordable. Join us to create the future of health! We at CYTENA strive to empower our customers to serve patients faster and better. To accelerate workflows and bring new insights into biotherapeutic drug development, we provide precise control of individual cells through automation and microtechnology. Our instruments offer automated isolation of single cells with assurance of clonality and selection based on cell morphology. We can isolate many common cell types including bacteria. Our high viability rates make our instruments compatible with cell line development, single cell analysis, and other … Type: | 1 | 1 | 0 | 69 |
 | Deep Lens (acquired by Paradigm) Accelerating clinical trial matching in oncology Deep Lens is a digital healthcare company focused on enabling faster recruitment of the best-suited cancer patients for clinical trials at the time of diagnosis using VIPER. Deep Lens’ AI-driven cloud platform gives care teams, trial coordinators and oncologists visibility into all available trials and the ability to collaborate on groundbreaking cancer research across all cancer types. Artificial Intelligence, Pharmaceuticals , Cancer Research, Oncology, and Pathology Type: | 6 | 1 | 3 | 5 |
 | Olaris, Inc Removing the Guesswork from Medicine Olaris is a precision medicine company leveraging metabolomics and machine learning for the discovery and development of its myOLARISTM diagnostics products, which aim to optimize treatments and outcomes for individual patients. Metabolite diagnostics empower therapeutic selection, treatment effectiveness monitoring, disease diagnosis, and target identification across indications and therapeutics areas, including oncology, solid-organ transplant, and neurodegeneration. Our mission is to remove the guesswork from medicine. Diagnostics, Machine Learning, Metabolomics, NMR, Mass Spectrometry, Statistics, Transplant, and Oncology Type: | 1 | 1 | 1 | 14 |
 | Murrieta Genomics Launching the Next Great Genomic Startups Murrieta Genomics is dedicated to advancing the use of genomic sequencing in precision medicine, agriculture, forensics, veterinary and direct to consumer applications by offering entrepreneurs access to the specialized equipment, know-how and mentors that can transform research into commercial enterprise. We are a true incubator, offering dedicated bench space to fledgling companies at basically zero cost, helping them to define their business model and validate their science, and then investing in the companies that “graduate” the incubator. We are located in the 16,000 square foot Murrieta Innovation Center in Southern California, in close proximity … | 1 | 1 | 0 | 7 |
 | Circuit Clinical An IRO committed to better access to clinical research, the development of new medicines, and health equity. Circuit Clinical, one of the fastest-growing research networks in the USA, is dedicated to empowering patients to choose clinical research as a care option through improved access to clinical trials. Committed to transforming the experience of finding, choosing, and participating in clinical research for physicians and their patients, Circuit provides clinical research services through traditional, hybrid, and decentralized community-based site models and their MD Prescreen service that optimizes patient referrals. Learn more at circuitclinical.com Clinical Research Enrollment Solutions, Patient Recruiting Services, Clinical Site … Type: | 11 | 1 | 7 | 101 |
 | HP Health Solutions Germany GmbH For more information, please visit www.gna-bio.com Laser PCR, Molecular Diagnostics, OEM, Molecular Technology, Biosecurity, Life Sciences, Food Safety, Nucleic Acid Amplification, Molecular Assays, Biotechnology, and Nanotechnology Type: | 1 | 0 | 0 | 27 |
 | BIO-LUTIONS Renaturing the World of Materials BIO-LUTIONS is pioneering the dry molding production technology to create sustainable packaging solutions made in Germany. Our fibre-based packaging products are completely recyclable (CEPI certification) and an affordable and scalable alternative to single-use plastic. Circular Economy Type: | 0 | 0 | 0 | 12 |
 | Regulaxis SAS Regenerative Medicine - Growth Disregulation - Oncology REGULAXIS is a French innovative biotechnology company based at BIOCITECH the technology park of life science of Paris North area. The company is engaged in the research, development and licensing of innovative synthetic molecules for use in human therapies. Its mission is to grant licenses of innovative molecules in a pharmaceutical company after the establishment of a phase II clinical record. REGULAXIS leads its R&D on its own premises, particularly in regard to biochemical and biological experiments, and keeps the mastery of the chemical synthesis of its therapeutic molecules. The company develops its … Type: | 0 | 0 | 0 | 3 |
Startup